Search Results 1351-1360 of 22056 for Inhibition

1. Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial Of QPI-1007 In Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) - Mayo Clinic

   Planned use of PDE5 inhibitor during study. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most up ...

2. Phase 3 Study Of T-DXd And Rilvegostomig Versus SoC In Advanced HER2-expressing Biliary Tract Cancer - Mayo Clinic

   * Prior exposure to other HER2 targeting therapies, ADCs, immune checkpoint inhibitors and therapeutic anticancer vaccines. * Histologically confirmed ...

3. Obstetrics and Gynecology Clinical Trials - Medical Professionals

   The four cancer types are: Non-Small Cell Lung Cancer (NSCLC) and melanoma that are progressing on checkpoint inhibitor (CPI, generally refers to anti-PD(L) ...

4. Clinical trials - Oncology (Medical)

   The purpose of this study is to evaluate ALPN-202 with PD-1 inhibition to treat adults with advanced solid tumors or lymphoma. A Study to Create a Registry ...

5. Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer - Mayo Clinic

   Patients must not require treatment with a RANKL inhibitor (e.g. denosumab) who cannot discontinue it before treatment with atezolizumab; Absolute neutrophil ...

6. Safety And Potential Bioactivity Of CLBS16 In Patients With Coronary Microvascular Dysfunction And Without Obstructive Coronary Artery Disease - Mayo Clinic

   ... inhibitor, beta blocker, calcium channel blocker, and/or ranolazine (unless ineffective or not tolerated)). Able to provide signed informed consent ...

7. April 2, 2012 Joe Dangor 507-284-5005 (days) 507-284-2511 (evenings) Email: newsbureau@mayo.edu Mayo Clinic: Nutritional Supple

   pancreatic cancer, had a modest effect on cell inhibition. When researchers combined GLA with gemcitabine, the cell growth was inhibited completely. -next ...

8. A Study to Assess the Efficacy, Safety, and Tolerability of Oral LPCN 1148 in Male Subjects With Cirrhosis of the Liver and Sarcopenia - Mayo Clinic

   History of significant sensitivity or allergy to testosterone, or product excipients. 30. Use of known strong inhibitors (e.g., ketoconazole) or inducers (e.g., ...

9. Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD) - Mayo Clinic

   If currently taking an acetylcholinesterase inhibitor and/or memantine, the subject must have been taking such medication(s) for ≥3 months. The dosage ...

10. Barrett's Esophagus Clinical Trials - Mayo Clinic Research

    The purpose of this study is to learn more about the prevalence of gastroesophageal reflux among patients with esophagitis using long term proton-pump-inhibitor ...